Following a partnership with the European Industrial Hemp Association (EIHA) and active participation with the Food Standards Agency (FSA), JM Wholesale has had more than 750 items included on the public CBD list.
Earlier this year the FSA published its list of CBD products linked to what it deems as credible Novel Food applications. Products included on the list will be advancing through the final stages towards authorisation, expected by 2023.
More than 900 applications for thousands of UK products have been submitted for approval, with the majority being rejected for lacking basic information such as toxicity levels.
JM Wholesale has announced that it has now had 750 of its products included on the public list.
Read more: FSA CBD list now closed for applications
Thomas Lowe, operations director at the Leicester-based company, said that, after 200 per cent business growth in the past 18 months and a resulting move to major new premises, JM Wholesale is now perfectly placed to consolidate its position as the UK’s premier CBD wholesaler.
Lowe commented: “We have a larger range of approved CBD products than any other distributor and this moment is another milestone for our company.
“We’ve worked hard to ensure that our customers and our business are protected, by getting rid of any products not published on the FSA’s website, regardless of how big those brands are.
“In fact we’ve always loved finding unique products, including those where the CBD can be absorbed in different ways. That way, more people from different walks of life can enjoy CBD no matter how they prefer to access it.
“From our distribution centre we now provide the largest range of isolate and full spectrum CBD products in the UK, all of which are 100 per cent accepted by the FSA.
“We are the first distributor to add the relevant Novel Food classification numbers to all of our relevant listed products.
“The past few months have been extremely challenging for our industry but we have made efforts to take an active role in the novel food submission process. We anticipated regulation of this industry, we were determined not to let it stand in the way of the growth of our business, and we’ve participated accordingly.
“All in all, this is excellent news for our customers and partners.”
The company has stated that it has experienced rapid growth off the back of increased awareness of the health benefits of CBD products in the UK, and that, alongside its consumer business, it also exports to suppliers in the UK and in 170 countries worldwide.
[activecampaign form=31]
- UK CBD market growth sees wholesaler move to larger premises
- House approves inclusion of SAFE Banking Act in must-pass NDAA
- A new frontier in medicine: MGC Pharma discusses drug delivery innovation
- Youngest member elected to European Industrial Hemp Association board
- Mixed response from CBD industry to publication of FSA product list